Aptamer modified Liposome Development Service for Targeted Drug Delivery
At Creative Biolabs, we bridge the gap between potent therapeutic payloads and their precise biological targets through our advanced aptamer-functionalized liposomal platforms. By leveraging high-affinity aptamers as "chemical antibodies", we engineer smart delivery vehicles capable of navigating complex biological barriers to reach specific microorganism, cells, tissues, or organelles. Our dedicated team combines cutting-edge Module Delivery Systems with proprietary conjugation technologies, establishing Creative Biolabs as a premier partner in the development of next-generation precision medicines.
Start Your Aptamer-modified Liposomes Project
The Science of Aptamer-modified Liposomes
The Power of Aptamers in Targeting
Aptamers are short, single-stranded DNA or RNA oligonucleotides selected via Systematic Evolution of Ligands by Exponential Enrichment to bind targets with high affinity and specificity. Unlike protein-based antibodies, aptamers offer superior tissue penetration due to their smaller size, lower immunogenicity, and exceptional chemical stability. They can be engineered to recognize a vast array of targets, from cell surface receptors (e.g., Nucleolin, PSMA) to specific small molecules.
Fig. 1 Selection procedure of cell-internalizing DNA aptamer using cell-SELEX.1,3
Aptamers-mediated Targeted Drug Delivery Strategies
To utilize the precise targeting capabilities of aptamers, therapeutic strategies are generally categorized into two primary approaches. Creative Biolabs specializes in the optimization of these systems to maximize the therapeutic index.
By anchoring aptamers to the surface of a liposome, we combine the high specificity of the aptamer with the extensive payload capacity of the lipid vesicle. This hybrid system provides a protective shell for labile cargoes (such as mRNA or siRNA) and facilitates the delivery of a high concentration of therapeutic molecules per binding event.
This strategy involves the direct covalent linkage of a therapeutic agent to a specific aptamer sequence. By utilizing the intrinsic affinity of the aptamer for a target receptor, the drug is guided directly to the site of action.
Advantages of Aptamer-modified Liposomes
Integrating aptamers into liposomal formulations offers distinct advantages over conventional passive targeting (EPR effect) or antibody-based targeting:
- Enhanced Cellular Uptake: Aptamers facilitate active receptor-mediated endocytosis, effectively transporting the liposome and its cargo into the cell cytoplasm.
- Low Immunogenicity: Nucleic acid aptamers are generally non-immunogenic compared to protein ligands, reducing the risk of accelerated blood clearance (ABC) upon repeated dosing.
- Versatile Chemical Modification: Aptamers can be easily synthesized with specific functional groups (thiol, amine, biotin) for precise, site-specific conjugation to liposomes without affecting their 3D folding structure.
- Stability: They maintain functionality across a wider range of temperatures and pH levels than antibodies, simplifying storage and handling.
Fig. 2 Aptamer-mediated targeted drug delivery system.2,3
Common Aptamers for Liposome Modification
Aptamers act as precise molecular guides when conjugated to liposomes. By selecting sequences that specifically recognize overexpressed receptors on diseased cells, researchers can achieve highly targeted delivery. The following table lists several well-characterized aptamers commonly employed to functionalize liposomes for therapeutic applications:
| Aptamer | Target | Application |
|---|---|---|
| A10 / A9 (RNA) | PSMA (Prostate-Specific Membrane Antigen) | Prostate cancer targeting |
| Sgc8 (DNA) | PTK7 (Protein Tyrosine Kinase 7), CCRF-CEM cell | Leukemia (T-cell ALL), Colon cancer, A549 cells |
| Endo28 (DNA) | Annexin A2 | Ovarian cancer |
| FKN-S2 (DNA) | Fractalkine | Colon adeno-carcinoma |
| ACE4 | Annexin A2 | MCF-7 cells |
| SRZ1 (DNA) | 4T1 cells | Breast cancer |
| EpCAM-Ap | EpCAM | Colorectal Cancer |
| XEO2mini (RNA) | PC3 cells | Prostate cancer |
| 5TR1 (DNA) | Mucin-1 | MCF-7 and C26 cells |
| AIR-3A (RNA) | IL-6R | IL-6R-carrying cells |
| AS-14 (DNA) | Fibronectin protein | Ehrlich carcinoma |
| FKN-S2 (DNA) | Fractalkine | Colon adeno-carcinoma |
| TLS1c (DNA) | MEAR cells | Hepatoma |
| S15 (DNA) | NSCLC | A549 cells |
| HB5 (DNA) | HER2 | SK-BR-3 cells |
Comprehensive Aptamer-modified Liposome Development Services
Creative Biolabs provides end-to-end solutions for the design, synthesis, and characterization of aptamer-modified liposomes. We have structured our services to address the specific needs of advanced drug delivery research.
Before conjugation, securing high-quality ligands is critical. We offer comprehensive upstream services to generate and optimize aptamers for your specific targets.
- Custom Aptamer Screening: Selection of high-affinity aptamers against cell surface markers, proteins, or small molecules using aptamer screening protocols.
- Sequence Optimization: Truncation and mutagenesis studies to identify the minimal binding motif, enhancing synthesis efficiency and reducing steric bulk.
- Chemical Stabilization: Incorporation of modified nucleotides (e.g., 2'-OMe, 2'-F) to enhance nuclease resistance and in vivo stability.
Workflow
Revolutionizing Research with Aptamer-modified Liposomes
- Precision Oncology & MDR Reversal Leverages aptamer-mediated endocytosis to bypass efflux pumps, significantly increasing intracellular drug concentrations in multidrug-resistant tumors.
- CNS & Blood-Brain Barrier Traversal Utilizes receptor-targeting aptamers (e.g., TfR) to facilitate transcytosis across the BBB for non-invasive delivery to the central nervous system.
- Gene Editing & RNA Interference Shields nucleic acid payloads from degradation and targets specific cell types to minimize off-target editing and immune activation.
- Targeted Immunotherapy Directs immune modulators to specific immune cells (APCs, T-cells) to potentiate vaccine responses without systemic toxicity.
- Theranostics & Molecular Imaging Combines therapeutics with imaging agents to enable real-time monitoring of drug distribution and treatment efficacy.
Why Choose Creative Biolabs?
Proprietary Module Delivery Systems
We utilize a modular platform that allows for rapid "mix-and-match" optimization of lipid backbones and aptamer ligands to suit specific therapeutic goals.
High-Fidelity Conjugation
Our optimized chemistry ensures high ligand density (aptamers/liposome) without compromising the tertiary structure or biological activity of the aptamer.
Scalability & Stability
We bridge the gap between discovery and development, offering scalable production and proprietary lyophilization protocols for shelf-stable, Aptamer-Conjugated Liposome products.
Expert Scientific Support
Our team acts as an extension of your lab, providing deep technical insights on aptamer selection, linker chemistry, and troubleshooting throughout the project.
Customization Flexibility
We tailor every aspect—size, charge, payload, and linker strategy—to your specific biological question.
At Creative Biolabs, we are dedicated to advancing the frontiers of precision medicine. By integrating high-affinity aptamers with robust liposomal delivery systems, we provide researchers with the tools to solve critical bioavailability and targeting challenges.
Related Services
FAQs
How does aptamer targeting compare to antibody targeting in liposomal formulations?
While both provide active targeting, aptamers in Aptamer-Conjugated Liposomes often exhibit higher stability and lower immunogenicity. Aptamers are smaller, allowing for better tumor penetration, and their chemical synthesis ensures high batch-to-batch consistency compared to biological antibody production.
Can your Aptamer-Conjugated Liposomes encapsulate both hydrophilic and hydrophobic drugs?
Yes. Our hybrid systems are designed with a lipid bilayer (ideal for hydrophobic drugs like Paclitaxel) and an aqueous core (ideal for hydrophilic drugs like Doxorubicin), allowing for the co-delivery of synergistic therapies within a single targeted vehicle.
What is the stability of your aptamer-modified liposomes?
Liquid formulations are typically stable for weeks at 4°C. However, we highly recommend our Lyophilization Service for long-term storage. Our specialized freeze-drying protocols preserve the structural integrity of the liposome and the binding affinity of the aptamer for months to years.
Do you offer scale-up services for animal studies?
Absolutely. We can scale production from milligram quantities for in vitro screening to gram-scale batches suitable for in vivo preclinical efficacy and toxicology studies.
References
- Fu, Zhaoying, and Jim Xiang. "Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy." International journal of molecular sciences 21.23 (2020): 9123. https://doi.org/10.3390/ijms21239123.
- Yan, Shuxin, et al. "Different targeting ligands-mediated drug delivery systems for tumor therapy." Pharmaceutics 16.2 (2024): 248. https://doi.org/10.3390/pharmaceutics16020248.
- Distributed under Open Access license CC BY 4.0, without modification.
